Description
resiba FlexTouch is a long-acting insulin formulation containing insulin degludec, designed to provide basal insulin coverage for individuals with diabetes mellitus. Each pre-filled pen contains 300 units of insulin degludec in 3 mL of solution, delivering 100 units per milliliter. Tresiba is administered subcutaneously once daily, at any time of day, with the option to adjust the dosing time as needed. It is used to improve glycemic control in adults and children aged 1 year and older with type 1 or type 2 diabetes mellitus. Tresiba FlexTouch is compatible with Novo Nordisk insulin delivery systems and is available by prescription.
 10 ML.jpeg)
Change Language